Shinya Sugimoto

Shinya Sugimoto

Auto-generated profile, based on publicly available information

Shinya Sugimoto

Division of Gastroenterology and Hepatology, Department of Internal Medicine Keio University School of Medicine Tokyo Japan

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2021 in Nature
Verified
Journal Article
Closed access
PDF file
SSShinya Sugimoto
Shinya Sugimoto
EKEiji Kobayashi
Eiji Kobayashi
MFMasayuki Fujii
Masayuki Fujii
YOYuki Ohta
Yuki Ohta
KAKazuya Arai
Kazuya Arai
TSToshiro Sato
Toshiro Sato

1 January 2015 in World Journal of Gastroenterology
Verified
Journal Article
Open access
SSShinya Sugimoto
Shinya Sugimoto
TMTakeshi Mizukami
Takeshi Mizukami
Colonoscopy techniques combining or replacing air insufflation with water infusion are becoming increasingly popular. They were originally designed to reduce colonic spasms, facilitate cecal intubation, and lower patient discomfort and the need for sedation. These maneuvers straighten the rectosigmoid colon and enable the colonoscope to be inserted deeply without causing looping of the colon. Water-immersion colonoscopy minimizes colonic distension and improves visibility by introducing a small amount of water. In addition, since pain during colonoscopy indicates risk of bowel perforation and sedation masks this important warning, this method has the potential to be the favored insertion technique because it promotes patient safety without sedation. Recently, this water-immersion method has not only been used for colonoscope insertion, but has also been applied to therapy for sigmoid volvulus, removal of lesions, lower gastrointestinal bleeding, and therapeutic diagnosis of abnormal bowel morphology and irritable bowel syndrome. Although a larger sample size and prospective head-to-head-designed studies will be needed, this review focuses on the usefulness of water-immersion colonoscopy for diagnostic and therapeutic applications.

24 January 2022 in Stem Cells
Verified
Journal Article
Open access
PDF file
YWYusuke Wakisaka
Yusuke Wakisaka
SSShinya Sugimoto
Shinya Sugimoto
TSToshiro Sato
Toshiro Sato
Inflammatory bowel disease (IBD) is a chronic relapsing-remitting inflammatory disease of the gastrointestinal tract with an unknown etiology, and its incidence is increasing worldwide. Recent advances in immunomodulatory therapeutic agents such as biologics and small-molecule inhibitors have improved the prognosis of patients with IBD. However, some patients are refractory and resistant to these immunomodulatory therapies, and new therapies are needed. Given the importance of the intestinal epithelium in IBD pathogenesis, the difficulty of culturing intestinal epithelial cells (IECs) for long periods remains an obstacle in IBD research. Over the past 15 years, intestinal stem cells have been identified, and the in vivo microenvironment, called the niche, required for their maintenance has been elucidated, making the permanent culture of IECs possible. Recapitulating the niche in vitro, the intestinal epithelium forms 3-dimensional structures called organoids that simulate the intestinal epithelium in vivo. The intestinal epithelium plays an important role in the intestinal barrier and immunomodulatory functions and serves as a physical structure that separates the intestinal lumen from the body. Recent studies have revealed that functional disruption of the intestinal epithelium is closely related to the pathogenesis of IBD, and IBD research using organoids has attracted attention. In this review, we discuss the application of adult tissue-derived organoids culture technology to elucidate the pathogenesis of IBD and to develop novel therapies, including regenerative treatments.

1 September 2019 in Digestive and Liver Disease
Verified
Journal Article
Closed access
MMMakoto Mutaguchi
Makoto Mutaguchi
MNMakoto Naganuma
Makoto Naganuma
SSShinya Sugimoto
Shinya Sugimoto
TFTomohiro Fukuda
Tomohiro Fukuda
KNKosaku Nanki
Kosaku Nanki
TKTakanori Kanai
Takanori Kanai

7 June 2015 in Journal of Gastroenterology
Verified
Journal Article
Closed access
PDF file
SSShinya Sugimoto
Shinya Sugimoto
HKHirokazu Komatsu
Hirokazu Komatsu
YMYuichi Morohoshi
Yuichi Morohoshi
TKTakanori Kanai
Takanori Kanai

1 January 2022 in The Keio Journal of Medicine
Verified
Journal Article
Open access
PDF file
SSShinya Sugimoto
Shinya Sugimoto
EKEiji Kobayashi
Eiji Kobayashi
TKTakanori Kanai
Takanori Kanai
TSToshiro Sato
Toshiro Sato
Our understanding of the biology of the intestinal epithelium has advanced since the establishment of an organoid culture system. Although organoids have enabled investigation of the mechanism of self-renewal of human intestinal stem cells in vitro, it remains difficult to clarify the behavior of human normal and diseased intestinal epithelium in vivo. Recently, we developed a xenotransplantation system in which human intestinal organoids are engrafted onto epithelium-depleted mouse colons. This xenograft recapitulated the original tissue structures. Upon xenotransplantation, normal colon organoids developed normal colon crypt structures without tumorigenesis, whereas tumor-derived organoids formed colonic tumors resembling the original tumors. The non-tumorigenicity of human intestinal organoids highlights the safety of organoid-based regenerative medicine. As an example of regenerative medicine for short bowel syndrome, we devised a unique organ-repurposing approach to convert colons into small intestines by organoid transplantation. In this approach, the transplanted rat small intestinal organoids not only engrafted onto the rat colons but also remodeled the colon subepithelial structures into a small intestine-like conformation. Luminal flow accelerated the maturation of villi in the small intestine, which promoted the formation of a lymphovascular network mimicking lacteals. In this review, we provide an overview of recent advances in gastrointestinal organoid transplantation and share our understanding of human disease biology and regenerative medicine derived from these studies.